Pet Biotics Market Size, Share and Forecast 2026 to 2035
Share With :
Pet Biotics Market Size is valued at USD 847.21 Mn in 2025 and is predicted to reach USD 1,889.12 Mn by the year 2035 at a 8.8% CAGR during the forecast period for 2026 to 2035.
Pet Biotics Market Size, Share & Trends Analysis Distribution by Product Type (Probiotics, Prebiotics, Postbiotics), Application (Dry Food, Wet Food, Supplements, Snacks & Treats), by pets (Dogs, Cats, Other Pets (Birds, Equine, And Other Small Mammals)), by function (Digestive/Gut Health, Immune Modulation, Metabolic & Weight Management, Oral & Dental Health, Other Functions), by form(dry, wet), by Manufacturing Technology (Fermentation, Centrifugation & Filtration, Drying & Stabilization, Encapsulation & Protection, Inactivation & Cell Disruption, Formulation & Blending, Quality Control & Storage),and Segment Forecasts, 2026 to 2035
Pet biotics are natural health products designed to support pets' overall well-being, focusing on gut health, immunity, and digestion. These beneficial ingredients include probiotics, prebiotics, and postbiotics, which are added to pet food, treats, and supplements to support pets' health and activity. With growing awareness among pet owners about the importance of preventive care and proper nutrition, pet biotics are becoming an essential part of daily pet care. They offer a natural, safe, and effective way to enhance pets’ well-being and quality of life across dogs, cats, and other small animals. As more people understand how important gut health is for pets’ overall wellness, nutrition, and long-term health, the demand for pet biotics is increasing rapidly.
The pet biotics market is growing rapidly as more pet owners focus on their pets’ health and well-being. One of the main reasons behind this growth is the increasing awareness of gut health, with owners seeking probiotics, prebiotics, and postbiotics to support digestion and immunity. Pet humanization also plays a role, as pets are treated like family members, encouraging spending on premium health products. Preventive care and functional nutrition are gaining attention, with owners choosing products to avoid health issues. Veterinarian recommendations influence adoption, as professionals guide owners on the benefits of biotics. Additionally, innovation in product formulation and easier availability of foods, treats, and supplements are further fueling market growth.
The challenges in the pet biotics industry remain limited, with long-term research showing that certain biotic strains are effective for pets, which can make both veterinarians and pet owners hesitant. Another issue is maintaining product quality, as the beneficial bacteria can lose their strength during production, storage, or transport. Cost is also a concern, since high-quality pet biotic products are often more expensive and may not be affordable for everyone.
In addition, some pet owners are still not fully aware of how pet biotics work or how they benefit their pets, which can slow wider adoption. One major opportunity in the pet biotics market is the growing demand for personalized and condition-specific pet nutrition. Pet owners are increasingly looking for targeted solutions for issues such as sensitive digestion, allergies, weight management, and immune support. This creates strong potential for pet biotic products tailored to specific life stages, breeds, or health conditions, offered through cust
• ADM (US)
• Alltech (US)
• dsm-firmenich (Netherlands)
• International Flavors & Fragrances Inc. (US)
• Kerry Group plc (Ireland)
• Cargill, Incorporated (US)
• Probi (Sweden)
• Kemin Industries, Inc. (US)
• BENEO GmbH (Germany)
• Ingredion (US)
• Lallemand Inc. (Canada)
• Sacco System (Italy)
• Phileo by Lesaffre (France)
• Sanzyme Biologics (India)
• Orffa (Netherlands)
The pet biotics market is mainly driven by the growing awareness about the importance of gut health is for pets. Pet owners are learning that a healthy gut supports better digestion, stronger immunity, and overall well-being. As a result, many are choosing products that contain probiotics, prebiotics, and postbiotics to help their pets stay healthy and comfortable. This shift in understanding has encouraged owners to be more proactive about their pets’ nutrition, making gut-health-focused products a regular part of daily pet care. This awareness is shaping buying decisions and playing a key role in the steady growth of the pet biotics market.
One of the biggest challenges in the pet biotics market is the lack of strong, long-term scientific research proving the effectiveness of specific biotic strains in pets. While short-term benefits are often reported, limited clinical studies make some veterinarians cautious about regularly recommending these products. This uncertainty can also affect pet owners, who may hesitate to invest in biotic supplements without clear evidence of long-term results. As a result, trust and confidence in pet biotics can develop slowly. Additionally, inconsistent research findings across different products and strains make it harder to set clear guidelines. Until more validated studies and clinical data are available, this challenge is likely to continue affecting wider adoption and market growth.
The Pet Biotics market is segmented across several key dimensions: product type, application, pet type, function, form, and manufacturing technology. By product type, the market includes probiotics, prebiotics, and yeast & fungi, catering to different nutritional and health needs. Segmentation by application covers major uses such as dry food, wet food, supplements, and snacks & treats.
The market is also analyzed by pet type, including dogs, cats, and other pets such as birds, equine, and other small mammals, reflecting the diverse target audience for these products. Functional segmentation focuses on digestive/gut health, immune modulation, metabolic & weight management, oral & dental health, and other specific health functions. By form, products are categorized into dry and wet formats to suit various feeding preferences. Finally, the market is defined by manufacturing technology, encompassing fermentation, centrifugation & filtration, drying & stabilization, encapsulation & protection, inactivation & cel
The postbiotics and beneficial microbes segment, including lactobacillus, bifidobacterium, and yeast strains such as Saccharomyces Boulardii and Saccharomyces Cerevisiae, held a significant share in the pet biotics market. This growth is driven by the increasing awareness of gut health and the role of beneficial microbes in supporting digestion, immunity, and overall wellness in pets. These strains are favored for their stability, safety, and effectiveness, making them suitable for inclusion in pet food, treats, and supplements. The demand for this segment is further boosted by veterinarians recommending these microbes to manage digestive issues, maintain gut balance, and promote preventive health in dogs, cats, and other small pets.
The Supplement segment is expected to grow at the fastest rate in the pet biotics market, and for better reasons. Pet supplements are an easy and effective way to deliver probiotics, prebiotics, and postbiotics directly to pets, helping support digestion, strengthen immunity, and improve overall health. Unlike functional foods, supplements allow for precise dosing and can be tailored to specific health needs, such as sensitive digestion, weight management, or immune support.
The convenience of capsules, powders, chewables, and soft treats makes them highly appealing to pet owners. Increasing awareness of preventive care, recommendations from veterinarians, and the trend of treating pets as family members are all driving the strong adoption and rapid growth of this segment.
Asia Pacific is emerging as a leader in the pet biotics market due to several key factors. The region is seeing a rapid increase in pet ownership, with more households adopting dogs, cats, and other small pets. Pet owners are increasingly aware of the importance of digestive health, immunity, and overall wellness, driving demand for probiotics, prebiotics, and postbiotics.
Rising disposable incomes and a growing middle class make premium pet nutrition products more accessible. Additionally, expanding retail and e-commerce channels, along with the introduction of innovative pet supplements and foods, are making biotic products easier to purchase. Together, these factors position Asia Pacific at the forefront of market growth.
| Report Attribute | Specifications |
| Market size value in 2025 | USD 847.21 Mn |
| Revenue forecast in 2035 | USD 1,889.12 Mn |
| Growth Rate CAGR | CAGR of 8.8 from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Mn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2024 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product Type, Pet Type, Form, Function, Manufacturing technology and by Region. |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | ADM(US), Alltech(US), dsm-firmenich(Netherlands), International Flavors & Fragrances Inc.(US), Kerry Group plc(Ireland), Cargill, Incorporated (US), Probi (Sweden), Kemin Industries, Inc.(US), BENEO GmbH(Germany), Ingredion(US), Lallemand Inc.(Canada), Sacco System(Italy), Phileo by Lesaffre(France), Sanzyme Biologics(India), Orffa(Netherlands) |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
• The US
• Canada
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• GCC Countries
• South Africa
• Rest of Middle East and Africa
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.